Sleep Apnea Devices Market Report 2024 (Global Edition)

What are the Factors Driving the Growth of Sleep Apnea Devices Market?

• Growing incidence of Sleep apnea Sleep Apnea Devices Market

The rising prevalence of sleep apnea is a major driving force in the sleep apnea devices market. Sleep apnea is a common sleep problem that affects a large percentage of the world's population. A variety of reasons contribute to the increasing prevalence of sleep apnea. The growing obesity pandemic is one important factor. Obesity is a key risk factor for sleep apnea because excess weight narrows the airway, increasing the possibility of airway obstruction while sleeping. The prevalence of sleep apnea has increased in parallel with the global rise in obesity rates, particularly in wealthy countries. Another element that contributes is the ageing population. Sleep apnea becomes increasingly common as people age, and as the world population ages, the number of persons affected grows. For instance, according to the national library of medicine report, Obstructive sleep apnea affects 3 to 7% of men and 2 to 5% of women in the general population. Obese people have very high rates.

• Growing aging population of Sleep Apnea Devices Market

The ageing population is a primary driver of the sleep apnea devices market. As the world's population ages, the prevalence of sleep apnea rises. Sleep apnea is becoming increasingly common among the elderly due to a variety of circumstances. With ageing, the muscles and tissues in the airway lose flexibility, making them more prone to collapsing and obstructing airflow during sleep. Furthermore, age-related alterations in respiratory control systems, as well as an increased incidence of comorbidities such as obesity, hypertension, and cardiovascular disease, contribute to the development of sleep apnea in the aged population. As a result, there is a growing demand for sleep apnea devices among older persons to manage this sleep problem and improve their quality of life. The growing need of an ageing population. For instance, according to the national library of medicine OSA prevalence estimates in older persons may be as high as 70% in men and 56% in women.

• Inadequate Awareness and Diagnosis

The lack of awareness and diagnosis of sleep apnea is a significant limitation for the sleep apnea equipment market. Many people go neglected or are unaware of their disease, resulting in a major gap in recognising and treating sleep apnea cases. Snoring, excessive daytime sleepiness, and exhaustion are all signs of sleep apnea that are sometimes misattributed to other causes or just ignored. The general public's and even healthcare experts' lack of information can lead to delayed or missing diagnoses. For instance, according to the National Sleep Foundation, sleep apnea affects up to 20% of the population, and around 85% of people with sleep apnea are unaware of their condition. Two to four percent of all Americans have untreated sleep apnea. This accounts for around one in every fifty people going undiagnosed.

• Technical Challenges facing by Sleep Apnea Devices Market

The sleep apnea devices market has been restricted by technical challenges. Sleep apnea devices, particularly those involving complicated technologies or algorithms, may encounter technical difficulties that limit their use and effectiveness. Device faults, mistakes in pressure adjustments, and maintenance challenges can all affect the smooth operation of these devices. Individuals might experience discomfort, inconvenience, or disruptions in their treatment as a result of device-related difficulties, which can impair patient compliance and satisfaction. Furthermore, to overcome technological challenges, the development of sophisticated features and technologies in sleep apnea devices necessitates continual research and innovation. 

Current Trends of the Sleep Apnea Devices Market

• Portability and miniaturisation of Sleep Apnea Devices Market

Miniaturisation and mobility are important trends in the market for sleep apnea equipment. There is an increasing demand for sleep apnea devices that are compact, lightweight, and easy to carry, providing users with increased convenience and mobility. The miniaturisation of sleep apnea devices allows for a more discrete and less invasive experience, allowing people to use the devices comfortably and inconspicuously in a variety of contexts. Portable sleep apnea devices are especially useful for people who travel frequently or live an active lifestyle because they can easily bring their devices with them and maintain continuous treatment. For instance, in September 2022, Transcend Micro, the world's smallest and lightest portable continuous positive airway pressure (CPAP) device, was recently introduced by Transcend Inc. Transcend Micro, which weighs less than a half-pound and is less than four inches, is intended to make it easier for those with Obstructive Sleep Apnea to continue their sleep apnea therapy at home or while travelling. 

• Approach to Personalised Treatment

The movement in sleep apnea devices towards a personalised treatment approach is changing the way people receive care for their sleep apnea disease. Sleep apnea devices may now gather and analyse patient-specific data to adapt treatment settings and optimise therapy outcomes, thanks to developments in data analytics, machine learning, and remote monitoring capabilities. Sleep apnea devices enable individuals to actively participate in managing their disease and improve treatment efficacy by providing personalised treatment alternatives, thereby increasing their quality of sleep and general well-being. For instance, in 2019, Philips introduces Night Balance, a new therapy option for people with positional obstructive sleep apnea which can also be connected with the mobile application.

Impact of the COVID-19 Pandemic on Sleep Apnea Devices Market 

The COVID-19 epidemic has increased the introduction of telemedicine and remote monitoring in the market for sleep apnea devices. Virtual consultations and remote monitoring technologies for sleep apnea management were used by healthcare practitioners and patients to reduce the danger of virus transmission. Telemedicine enabled healthcare providers to evaluate and guide patients remotely, eliminating the need for in-person visits. This change to telemedicine not only provided continuity of care, but also enhanced access to sleep apnea diagnosis and treatment, especially for those who may have experienced challenges to traditional healthcare access.

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Sleep Apnea Devices Market is witnessing significant growth in the near future.

In 2023, the Therapeutic devices segment accounted for noticeable share of global Sleep Apnea Devices Market and is projected to experience significant growth in the near future.

The Hospital/ Clinics segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Cadwell Laboratories Inc.; Fisher & Paykel Healthcare; Invacare Corporation; Itamar Medical Ltd; Natus Medical Inc.; Nihon Kohden; Koninklijke Philips N.V.; ResMed Inc.; Teleflex Inc.; Drive DeVilbiss International, and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions (FAQs)